nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—ALB—Captopril—systemic scleroderma	0.244	0.366	CbGbCtD
Magnesium salicylate—ALB—Mycophenolate mofetil—systemic scleroderma	0.192	0.288	CbGbCtD
Magnesium salicylate—ALB—Prednisone—systemic scleroderma	0.153	0.23	CbGbCtD
Magnesium salicylate—ALB—Methotrexate—systemic scleroderma	0.077	0.116	CbGbCtD
Magnesium salicylate—PTGS2—skeletal joint—systemic scleroderma	0.0105	0.204	CbGeAlD
Magnesium salicylate—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00543	0.624	CbGdCrCtD
Magnesium salicylate—PTGS1—artery—systemic scleroderma	0.00461	0.0894	CbGeAlD
Magnesium salicylate—PTGS2—artery—systemic scleroderma	0.0044	0.0854	CbGeAlD
Magnesium salicylate—PTGS1—endothelium—systemic scleroderma	0.00389	0.0755	CbGeAlD
Magnesium salicylate—PTGS2—endothelium—systemic scleroderma	0.00372	0.0722	CbGeAlD
Magnesium salicylate—PTGS1—blood vessel—systemic scleroderma	0.00359	0.0696	CbGeAlD
Magnesium salicylate—PTGS2—blood vessel—systemic scleroderma	0.00343	0.0665	CbGeAlD
Magnesium salicylate—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00328	0.376	CbGdCrCtD
Magnesium salicylate—Oesophagitis—Mycophenolic acid—systemic scleroderma	0.00226	0.00827	CcSEcCtD
Magnesium salicylate—Asthma—Mometasone—systemic scleroderma	0.00225	0.00822	CcSEcCtD
Magnesium salicylate—Ecchymosis—Mycophenolic acid—systemic scleroderma	0.00224	0.00818	CcSEcCtD
Magnesium salicylate—Sweating—Pentoxifylline—systemic scleroderma	0.00223	0.00815	CcSEcCtD
Magnesium salicylate—Epistaxis—Pentoxifylline—systemic scleroderma	0.00219	0.00801	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Mycophenolate mofetil—systemic scleroderma	0.00213	0.0078	CcSEcCtD
Magnesium salicylate—Hepatitis—Pentoxifylline—systemic scleroderma	0.00209	0.00763	CcSEcCtD
Magnesium salicylate—Deafness—Mycophenolic acid—systemic scleroderma	0.00201	0.00734	CcSEcCtD
Magnesium salicylate—Lightheadedness—Lisinopril—systemic scleroderma	0.00199	0.00729	CcSEcCtD
Magnesium salicylate—Flushing—Pentoxifylline—systemic scleroderma	0.00194	0.00708	CcSEcCtD
Magnesium salicylate—Epistaxis—Mometasone—systemic scleroderma	0.00189	0.00692	CcSEcCtD
Magnesium salicylate—PTGS1—connective tissue—systemic scleroderma	0.00184	0.0357	CbGeAlD
Magnesium salicylate—Erythema—Pentoxifylline—systemic scleroderma	0.00182	0.00664	CcSEcCtD
Magnesium salicylate—Oesophagitis—Mycophenolate mofetil—systemic scleroderma	0.00178	0.00653	CcSEcCtD
Magnesium salicylate—Dysgeusia—Pentoxifylline—systemic scleroderma	0.00178	0.0065	CcSEcCtD
Magnesium salicylate—Ecchymosis—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00646	CcSEcCtD
Magnesium salicylate—PTGS2—connective tissue—systemic scleroderma	0.00176	0.0341	CbGeAlD
Magnesium salicylate—PTGS1—smooth muscle tissue—systemic scleroderma	0.00168	0.0327	CbGeAlD
Magnesium salicylate—PTGS1—skin of body—systemic scleroderma	0.00166	0.0322	CbGeAlD
Magnesium salicylate—Abdominal discomfort—Azathioprine—systemic scleroderma	0.00165	0.00604	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Mycophenolic acid—systemic scleroderma	0.00164	0.006	CcSEcCtD
Magnesium salicylate—Asthma—Leflunomide—systemic scleroderma	0.00163	0.00595	CcSEcCtD
Magnesium salicylate—PTGS2—smooth muscle tissue—systemic scleroderma	0.00161	0.0312	CbGeAlD
Magnesium salicylate—Burning sensation—Methotrexate—systemic scleroderma	0.00159	0.00582	CcSEcCtD
Magnesium salicylate—PTGS2—skin of body—systemic scleroderma	0.00159	0.0308	CbGeAlD
Magnesium salicylate—Deafness—Mycophenolate mofetil—systemic scleroderma	0.00159	0.0058	CcSEcCtD
Magnesium salicylate—Hepatitis—Captopril—systemic scleroderma	0.00158	0.00578	CcSEcCtD
Magnesium salicylate—Hallucination—Captopril—systemic scleroderma	0.00157	0.00575	CcSEcCtD
Magnesium salicylate—Asthma—Mycophenolic acid—systemic scleroderma	0.00155	0.00568	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Captopril—systemic scleroderma	0.00149	0.00547	CcSEcCtD
Magnesium salicylate—Confusional state—Pentoxifylline—systemic scleroderma	0.00149	0.00546	CcSEcCtD
Magnesium salicylate—Stupor—Methotrexate—systemic scleroderma	0.00148	0.00542	CcSEcCtD
Magnesium salicylate—Oedema—Pentoxifylline—systemic scleroderma	0.00148	0.00542	CcSEcCtD
Magnesium salicylate—Flushing—Captopril—systemic scleroderma	0.00147	0.00537	CcSEcCtD
Magnesium salicylate—Shock—Pentoxifylline—systemic scleroderma	0.00146	0.00533	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00143	0.00524	CcSEcCtD
Magnesium salicylate—Weight increased—Mycophenolic acid—systemic scleroderma	0.00141	0.00517	CcSEcCtD
Magnesium salicylate—Anorexia—Pentoxifylline—systemic scleroderma	0.00141	0.00517	CcSEcCtD
Magnesium salicylate—Asthma—Lisinopril—systemic scleroderma	0.0014	0.00511	CcSEcCtD
Magnesium salicylate—Hypotension—Pentoxifylline—systemic scleroderma	0.00138	0.00506	CcSEcCtD
Magnesium salicylate—Epistaxis—Leflunomide—systemic scleroderma	0.00137	0.00501	CcSEcCtD
Magnesium salicylate—Dysgeusia—Captopril—systemic scleroderma	0.00135	0.00493	CcSEcCtD
Magnesium salicylate—PTGS1—digestive system—systemic scleroderma	0.00133	0.0258	CbGeAlD
Magnesium salicylate—Sweating—Mycophenolic acid—systemic scleroderma	0.00133	0.00485	CcSEcCtD
Magnesium salicylate—Somnolence—Pentoxifylline—systemic scleroderma	0.00132	0.00482	CcSEcCtD
Magnesium salicylate—Epistaxis—Mycophenolic acid—systemic scleroderma	0.00131	0.00478	CcSEcCtD
Magnesium salicylate—Dyspepsia—Pentoxifylline—systemic scleroderma	0.0013	0.00477	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Azathioprine—systemic scleroderma	0.0013	0.00477	CcSEcCtD
Magnesium salicylate—Hepatitis—Leflunomide—systemic scleroderma	0.0013	0.00476	CcSEcCtD
Magnesium salicylate—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00129	0.00471	CcSEcCtD
Magnesium salicylate—Weight increased—Lisinopril—systemic scleroderma	0.00127	0.00465	CcSEcCtD
Magnesium salicylate—PTGS2—digestive system—systemic scleroderma	0.00127	0.0246	CbGeAlD
Magnesium salicylate—Constipation—Pentoxifylline—systemic scleroderma	0.00127	0.00463	CcSEcCtD
Magnesium salicylate—PTGS1—tendon—systemic scleroderma	0.00126	0.0245	CbGeAlD
Magnesium salicylate—Skin exfoliation—Prednisone—systemic scleroderma	0.00126	0.00462	CcSEcCtD
Magnesium salicylate—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00124	0.00455	CcSEcCtD
Magnesium salicylate—Hallucination—Mycophenolic acid—systemic scleroderma	0.00124	0.00452	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Leflunomide—systemic scleroderma	0.00123	0.0045	CcSEcCtD
Magnesium salicylate—Asthma—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00448	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00122	0.00447	CcSEcCtD
Magnesium salicylate—Anorexia—Mometasone—systemic scleroderma	0.00122	0.00446	CcSEcCtD
Magnesium salicylate—Oesophagitis—Prednisone—systemic scleroderma	0.00121	0.00442	CcSEcCtD
Magnesium salicylate—PTGS2—tendon—systemic scleroderma	0.00121	0.0235	CbGeAlD
Magnesium salicylate—Ecchymosis—Prednisone—systemic scleroderma	0.0012	0.00438	CcSEcCtD
Magnesium salicylate—Sweating—Lisinopril—systemic scleroderma	0.0012	0.00437	CcSEcCtD
Magnesium salicylate—Urticaria—Pentoxifylline—systemic scleroderma	0.00118	0.00431	CcSEcCtD
Magnesium salicylate—Epistaxis—Lisinopril—systemic scleroderma	0.00118	0.0043	CcSEcCtD
Magnesium salicylate—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00116	0.00424	CcSEcCtD
Magnesium salicylate—Confusional state—Captopril—systemic scleroderma	0.00113	0.00414	CcSEcCtD
Magnesium salicylate—Dyspepsia—Mometasone—systemic scleroderma	0.00113	0.00412	CcSEcCtD
Magnesium salicylate—Hepatitis—Lisinopril—systemic scleroderma	0.00112	0.00409	CcSEcCtD
Magnesium salicylate—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00408	CcSEcCtD
Magnesium salicylate—Hallucination—Lisinopril—systemic scleroderma	0.00111	0.00407	CcSEcCtD
Magnesium salicylate—Decreased appetite—Mometasone—systemic scleroderma	0.00111	0.00406	CcSEcCtD
Magnesium salicylate—Dysgeusia—Leflunomide—systemic scleroderma	0.00111	0.00406	CcSEcCtD
Magnesium salicylate—PTGS1—lung—systemic scleroderma	0.00111	0.0215	CbGeAlD
Magnesium salicylate—Shock—Captopril—systemic scleroderma	0.0011	0.00404	CcSEcCtD
Magnesium salicylate—Pain—Mometasone—systemic scleroderma	0.00109	0.004	CcSEcCtD
Magnesium salicylate—Anorexia—Captopril—systemic scleroderma	0.00107	0.00391	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.00107	0.00391	CcSEcCtD
Magnesium salicylate—PTGS2—lung—systemic scleroderma	0.00106	0.0206	CbGeAlD
Magnesium salicylate—Erythema multiforme—Lisinopril—systemic scleroderma	0.00106	0.00387	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Methotrexate—systemic scleroderma	0.00106	0.00386	CcSEcCtD
Magnesium salicylate—Hypotension—Captopril—systemic scleroderma	0.00105	0.00384	CcSEcCtD
Magnesium salicylate—Pruritus—Pentoxifylline—systemic scleroderma	0.00105	0.00383	CcSEcCtD
Magnesium salicylate—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00383	CcSEcCtD
Magnesium salicylate—Tinnitus—Lisinopril—systemic scleroderma	0.00104	0.00382	CcSEcCtD
Magnesium salicylate—Flushing—Lisinopril—systemic scleroderma	0.00104	0.0038	CcSEcCtD
Magnesium salicylate—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00377	CcSEcCtD
Magnesium salicylate—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00101	0.00371	CcSEcCtD
Magnesium salicylate—Ecchymosis—Methotrexate—systemic scleroderma	0.001	0.00366	CcSEcCtD
Magnesium salicylate—Somnolence—Captopril—systemic scleroderma	0.000998	0.00365	CcSEcCtD
Magnesium salicylate—Dyspepsia—Captopril—systemic scleroderma	0.000989	0.00362	CcSEcCtD
Magnesium salicylate—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000981	0.00359	CcSEcCtD
Magnesium salicylate—Lethargy—Prednisone—systemic scleroderma	0.000981	0.00359	CcSEcCtD
Magnesium salicylate—Dizziness—Pentoxifylline—systemic scleroderma	0.00098	0.00358	CcSEcCtD
Magnesium salicylate—Decreased appetite—Captopril—systemic scleroderma	0.000976	0.00357	CcSEcCtD
Magnesium salicylate—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000976	0.00357	CcSEcCtD
Magnesium salicylate—Erythema—Lisinopril—systemic scleroderma	0.000975	0.00356	CcSEcCtD
Magnesium salicylate—Constipation—Captopril—systemic scleroderma	0.00096	0.00351	CcSEcCtD
Magnesium salicylate—Dysgeusia—Lisinopril—systemic scleroderma	0.000954	0.00349	CcSEcCtD
Magnesium salicylate—Vomiting—Pentoxifylline—systemic scleroderma	0.000942	0.00345	CcSEcCtD
Magnesium salicylate—Rash—Pentoxifylline—systemic scleroderma	0.000934	0.00342	CcSEcCtD
Magnesium salicylate—Dermatitis—Pentoxifylline—systemic scleroderma	0.000934	0.00341	CcSEcCtD
Magnesium salicylate—Headache—Pentoxifylline—systemic scleroderma	0.000928	0.0034	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Captopril—systemic scleroderma	0.000926	0.00338	CcSEcCtD
Magnesium salicylate—Hypotension—Azathioprine—systemic scleroderma	0.000916	0.00335	CcSEcCtD
Magnesium salicylate—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000915	0.00334	CcSEcCtD
Magnesium salicylate—Pruritus—Mometasone—systemic scleroderma	0.000905	0.00331	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000895	0.00327	CcSEcCtD
Magnesium salicylate—Confusional state—Mycophenolic acid—systemic scleroderma	0.00089	0.00326	CcSEcCtD
Magnesium salicylate—Oedema—Mycophenolic acid—systemic scleroderma	0.000883	0.00323	CcSEcCtD
Magnesium salicylate—Anorexia—Leflunomide—systemic scleroderma	0.000882	0.00323	CcSEcCtD
Magnesium salicylate—Nausea—Pentoxifylline—systemic scleroderma	0.00088	0.00322	CcSEcCtD
Magnesium salicylate—Diarrhoea—Mometasone—systemic scleroderma	0.000875	0.0032	CcSEcCtD
Magnesium salicylate—Shock—Mycophenolic acid—systemic scleroderma	0.000869	0.00318	CcSEcCtD
Magnesium salicylate—Hypotension—Leflunomide—systemic scleroderma	0.000865	0.00316	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000854	0.00312	CcSEcCtD
Magnesium salicylate—Anorexia—Mycophenolic acid—systemic scleroderma	0.000842	0.00308	CcSEcCtD
Magnesium salicylate—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000836	0.00306	CcSEcCtD
Magnesium salicylate—Hypotension—Mycophenolic acid—systemic scleroderma	0.000825	0.00302	CcSEcCtD
Magnesium salicylate—Lethargy—Methotrexate—systemic scleroderma	0.00082	0.003	CcSEcCtD
Magnesium salicylate—Dyspepsia—Leflunomide—systemic scleroderma	0.000815	0.00298	CcSEcCtD
Magnesium salicylate—Vomiting—Mometasone—systemic scleroderma	0.000813	0.00297	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Azathioprine—systemic scleroderma	0.000808	0.00295	CcSEcCtD
Magnesium salicylate—Rash—Mometasone—systemic scleroderma	0.000806	0.00295	CcSEcCtD
Magnesium salicylate—Dermatitis—Mometasone—systemic scleroderma	0.000806	0.00295	CcSEcCtD
Magnesium salicylate—Decreased appetite—Leflunomide—systemic scleroderma	0.000805	0.00294	CcSEcCtD
Magnesium salicylate—Confusional state—Lisinopril—systemic scleroderma	0.000802	0.00293	CcSEcCtD
Magnesium salicylate—Headache—Mometasone—systemic scleroderma	0.000801	0.00293	CcSEcCtD
Magnesium salicylate—Oedema—Lisinopril—systemic scleroderma	0.000795	0.00291	CcSEcCtD
Magnesium salicylate—Pruritus—Captopril—systemic scleroderma	0.000795	0.00291	CcSEcCtD
Magnesium salicylate—Constipation—Leflunomide—systemic scleroderma	0.000792	0.00289	CcSEcCtD
Magnesium salicylate—Pain—Leflunomide—systemic scleroderma	0.000792	0.00289	CcSEcCtD
Magnesium salicylate—Somnolence—Mycophenolic acid—systemic scleroderma	0.000785	0.00287	CcSEcCtD
Magnesium salicylate—Shock—Lisinopril—systemic scleroderma	0.000783	0.00286	CcSEcCtD
Magnesium salicylate—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000777	0.00284	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000769	0.00281	CcSEcCtD
Magnesium salicylate—Diarrhoea—Captopril—systemic scleroderma	0.000768	0.00281	CcSEcCtD
Magnesium salicylate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000768	0.00281	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Leflunomide—systemic scleroderma	0.000763	0.00279	CcSEcCtD
Magnesium salicylate—Nausea—Mometasone—systemic scleroderma	0.00076	0.00278	CcSEcCtD
Magnesium salicylate—Anorexia—Lisinopril—systemic scleroderma	0.000758	0.00277	CcSEcCtD
Magnesium salicylate—Weight increased—Prednisone—systemic scleroderma	0.000756	0.00276	CcSEcCtD
Magnesium salicylate—Constipation—Mycophenolic acid—systemic scleroderma	0.000755	0.00276	CcSEcCtD
Magnesium salicylate—Pain—Mycophenolic acid—systemic scleroderma	0.000755	0.00276	CcSEcCtD
Magnesium salicylate—Hypotension—Lisinopril—systemic scleroderma	0.000743	0.00272	CcSEcCtD
Magnesium salicylate—Dizziness—Captopril—systemic scleroderma	0.000743	0.00272	CcSEcCtD
Magnesium salicylate—Urticaria—Leflunomide—systemic scleroderma	0.000735	0.00269	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000728	0.00266	CcSEcCtD
Magnesium salicylate—Vomiting—Captopril—systemic scleroderma	0.000714	0.00261	CcSEcCtD
Magnesium salicylate—Rash—Captopril—systemic scleroderma	0.000708	0.00259	CcSEcCtD
Magnesium salicylate—Dermatitis—Captopril—systemic scleroderma	0.000707	0.00259	CcSEcCtD
Magnesium salicylate—Somnolence—Lisinopril—systemic scleroderma	0.000707	0.00259	CcSEcCtD
Magnesium salicylate—Headache—Captopril—systemic scleroderma	0.000704	0.00257	CcSEcCtD
Magnesium salicylate—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000703	0.00257	CcSEcCtD
Magnesium salicylate—Dyspepsia—Lisinopril—systemic scleroderma	0.0007	0.00256	CcSEcCtD
Magnesium salicylate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000697	0.00255	CcSEcCtD
Magnesium salicylate—Asthma—Methotrexate—systemic scleroderma	0.000694	0.00254	CcSEcCtD
Magnesium salicylate—Decreased appetite—Lisinopril—systemic scleroderma	0.000691	0.00253	CcSEcCtD
Magnesium salicylate—Shock—Mycophenolate mofetil—systemic scleroderma	0.000686	0.00251	CcSEcCtD
Magnesium salicylate—Pain—Lisinopril—systemic scleroderma	0.00068	0.00249	CcSEcCtD
Magnesium salicylate—Constipation—Lisinopril—systemic scleroderma	0.00068	0.00249	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000674	0.00246	CcSEcCtD
Magnesium salicylate—Diarrhoea—Azathioprine—systemic scleroderma	0.000671	0.00245	CcSEcCtD
Magnesium salicylate—Nausea—Captopril—systemic scleroderma	0.000667	0.00244	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000666	0.00243	CcSEcCtD
Magnesium salicylate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000664	0.00243	CcSEcCtD
Magnesium salicylate—Hallucination—Prednisone—systemic scleroderma	0.000662	0.00242	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Lisinopril—systemic scleroderma	0.000655	0.0024	CcSEcCtD
Magnesium salicylate—Pruritus—Leflunomide—systemic scleroderma	0.000655	0.00239	CcSEcCtD
Magnesium salicylate—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000651	0.00238	CcSEcCtD
Magnesium salicylate—Dizziness—Azathioprine—systemic scleroderma	0.000648	0.00237	CcSEcCtD
Magnesium salicylate—Diarrhoea—Leflunomide—systemic scleroderma	0.000633	0.00232	CcSEcCtD
Magnesium salicylate—Urticaria—Lisinopril—systemic scleroderma	0.000632	0.00231	CcSEcCtD
Magnesium salicylate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000625	0.00228	CcSEcCtD
Magnesium salicylate—Vomiting—Azathioprine—systemic scleroderma	0.000623	0.00228	CcSEcCtD
Magnesium salicylate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00062	0.00227	CcSEcCtD
Magnesium salicylate—Drowsiness—Methotrexate—systemic scleroderma	0.000619	0.00226	CcSEcCtD
Magnesium salicylate—Rash—Azathioprine—systemic scleroderma	0.000618	0.00226	CcSEcCtD
Magnesium salicylate—Dermatitis—Azathioprine—systemic scleroderma	0.000617	0.00226	CcSEcCtD
Magnesium salicylate—Flushing—Prednisone—systemic scleroderma	0.000617	0.00226	CcSEcCtD
Magnesium salicylate—Headache—Azathioprine—systemic scleroderma	0.000614	0.00225	CcSEcCtD
Magnesium salicylate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000613	0.00224	CcSEcCtD
Magnesium salicylate—Dizziness—Leflunomide—systemic scleroderma	0.000612	0.00224	CcSEcCtD
Magnesium salicylate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000606	0.00222	CcSEcCtD
Magnesium salicylate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000604	0.00221	CcSEcCtD
Magnesium salicylate—Pain—Mycophenolate mofetil—systemic scleroderma	0.000596	0.00218	CcSEcCtD
Magnesium salicylate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000596	0.00218	CcSEcCtD
Magnesium salicylate—Sweating—Methotrexate—systemic scleroderma	0.000593	0.00217	CcSEcCtD
Magnesium salicylate—Vomiting—Leflunomide—systemic scleroderma	0.000589	0.00215	CcSEcCtD
Magnesium salicylate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000584	0.00214	CcSEcCtD
Magnesium salicylate—Epistaxis—Methotrexate—systemic scleroderma	0.000584	0.00214	CcSEcCtD
Magnesium salicylate—Rash—Leflunomide—systemic scleroderma	0.000584	0.00213	CcSEcCtD
Magnesium salicylate—Dermatitis—Leflunomide—systemic scleroderma	0.000583	0.00213	CcSEcCtD
Magnesium salicylate—Nausea—Azathioprine—systemic scleroderma	0.000582	0.00213	CcSEcCtD
Magnesium salicylate—Headache—Leflunomide—systemic scleroderma	0.00058	0.00212	CcSEcCtD
Magnesium salicylate—Erythema—Prednisone—systemic scleroderma	0.000579	0.00212	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000574	0.0021	CcSEcCtD
Magnesium salicylate—Pruritus—Lisinopril—systemic scleroderma	0.000563	0.00206	CcSEcCtD
Magnesium salicylate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000561	0.00205	CcSEcCtD
Magnesium salicylate—Rash—Mycophenolic acid—systemic scleroderma	0.000557	0.00204	CcSEcCtD
Magnesium salicylate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000556	0.00203	CcSEcCtD
Magnesium salicylate—Hepatitis—Methotrexate—systemic scleroderma	0.000556	0.00203	CcSEcCtD
Magnesium salicylate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000554	0.00202	CcSEcCtD
Magnesium salicylate—Headache—Mycophenolic acid—systemic scleroderma	0.000553	0.00202	CcSEcCtD
Magnesium salicylate—Nausea—Leflunomide—systemic scleroderma	0.00055	0.00201	CcSEcCtD
Magnesium salicylate—Diarrhoea—Lisinopril—systemic scleroderma	0.000544	0.00199	CcSEcCtD
Magnesium salicylate—Dizziness—Lisinopril—systemic scleroderma	0.000526	0.00192	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Methotrexate—systemic scleroderma	0.000525	0.00192	CcSEcCtD
Magnesium salicylate—Nausea—Mycophenolic acid—systemic scleroderma	0.000525	0.00192	CcSEcCtD
Magnesium salicylate—Tinnitus—Methotrexate—systemic scleroderma	0.000518	0.00189	CcSEcCtD
Magnesium salicylate—Vomiting—Lisinopril—systemic scleroderma	0.000506	0.00185	CcSEcCtD
Magnesium salicylate—Rash—Lisinopril—systemic scleroderma	0.000501	0.00183	CcSEcCtD
Magnesium salicylate—Dermatitis—Lisinopril—systemic scleroderma	0.000501	0.00183	CcSEcCtD
Magnesium salicylate—Headache—Lisinopril—systemic scleroderma	0.000498	0.00182	CcSEcCtD
Magnesium salicylate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000493	0.0018	CcSEcCtD
Magnesium salicylate—Erythema—Methotrexate—systemic scleroderma	0.000484	0.00177	CcSEcCtD
Magnesium salicylate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000477	0.00174	CcSEcCtD
Magnesium salicylate—Dysgeusia—Methotrexate—systemic scleroderma	0.000474	0.00173	CcSEcCtD
Magnesium salicylate—Nausea—Lisinopril—systemic scleroderma	0.000472	0.00173	CcSEcCtD
Magnesium salicylate—Oedema—Prednisone—systemic scleroderma	0.000472	0.00173	CcSEcCtD
Magnesium salicylate—Shock—Prednisone—systemic scleroderma	0.000465	0.0017	CcSEcCtD
Magnesium salicylate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000461	0.00169	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Prednisone—systemic scleroderma	0.000457	0.00167	CcSEcCtD
Magnesium salicylate—Anorexia—Prednisone—systemic scleroderma	0.00045	0.00165	CcSEcCtD
Magnesium salicylate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000443	0.00162	CcSEcCtD
Magnesium salicylate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000439	0.00161	CcSEcCtD
Magnesium salicylate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000439	0.00161	CcSEcCtD
Magnesium salicylate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000437	0.0016	CcSEcCtD
Magnesium salicylate—Dyspepsia—Prednisone—systemic scleroderma	0.000416	0.00152	CcSEcCtD
Magnesium salicylate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00151	CcSEcCtD
Magnesium salicylate—Decreased appetite—Prednisone—systemic scleroderma	0.000411	0.0015	CcSEcCtD
Magnesium salicylate—Constipation—Prednisone—systemic scleroderma	0.000404	0.00148	CcSEcCtD
Magnesium salicylate—Confusional state—Methotrexate—systemic scleroderma	0.000398	0.00146	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Prednisone—systemic scleroderma	0.000389	0.00142	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000382	0.0014	CcSEcCtD
Magnesium salicylate—Anorexia—Methotrexate—systemic scleroderma	0.000376	0.00138	CcSEcCtD
Magnesium salicylate—Urticaria—Prednisone—systemic scleroderma	0.000375	0.00137	CcSEcCtD
Magnesium salicylate—Hypotension—Methotrexate—systemic scleroderma	0.000369	0.00135	CcSEcCtD
Magnesium salicylate—Somnolence—Methotrexate—systemic scleroderma	0.000351	0.00128	CcSEcCtD
Magnesium salicylate—Dyspepsia—Methotrexate—systemic scleroderma	0.000348	0.00127	CcSEcCtD
Magnesium salicylate—Decreased appetite—Methotrexate—systemic scleroderma	0.000343	0.00125	CcSEcCtD
Magnesium salicylate—Pain—Methotrexate—systemic scleroderma	0.000338	0.00123	CcSEcCtD
Magnesium salicylate—Pruritus—Prednisone—systemic scleroderma	0.000334	0.00122	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Methotrexate—systemic scleroderma	0.000325	0.00119	CcSEcCtD
Magnesium salicylate—Diarrhoea—Prednisone—systemic scleroderma	0.000323	0.00118	CcSEcCtD
Magnesium salicylate—Urticaria—Methotrexate—systemic scleroderma	0.000314	0.00115	CcSEcCtD
Magnesium salicylate—Dizziness—Prednisone—systemic scleroderma	0.000312	0.00114	CcSEcCtD
Magnesium salicylate—Vomiting—Prednisone—systemic scleroderma	0.0003	0.0011	CcSEcCtD
Magnesium salicylate—Rash—Prednisone—systemic scleroderma	0.000298	0.00109	CcSEcCtD
Magnesium salicylate—Dermatitis—Prednisone—systemic scleroderma	0.000298	0.00109	CcSEcCtD
Magnesium salicylate—Headache—Prednisone—systemic scleroderma	0.000296	0.00108	CcSEcCtD
Magnesium salicylate—Nausea—Prednisone—systemic scleroderma	0.000281	0.00103	CcSEcCtD
Magnesium salicylate—Pruritus—Methotrexate—systemic scleroderma	0.000279	0.00102	CcSEcCtD
Magnesium salicylate—Diarrhoea—Methotrexate—systemic scleroderma	0.00027	0.000988	CcSEcCtD
Magnesium salicylate—Dizziness—Methotrexate—systemic scleroderma	0.000261	0.000955	CcSEcCtD
Magnesium salicylate—Vomiting—Methotrexate—systemic scleroderma	0.000251	0.000918	CcSEcCtD
Magnesium salicylate—Rash—Methotrexate—systemic scleroderma	0.000249	0.00091	CcSEcCtD
Magnesium salicylate—Dermatitis—Methotrexate—systemic scleroderma	0.000249	0.000909	CcSEcCtD
Magnesium salicylate—Headache—Methotrexate—systemic scleroderma	0.000247	0.000904	CcSEcCtD
Magnesium salicylate—Nausea—Methotrexate—systemic scleroderma	0.000234	0.000858	CcSEcCtD
